Rodrigo Madurga de Lacalle

10PUBLICATIONS
53CO-AUTHORS
Molecular targetsPredictive and prognostic markersSignal transductionIntensive careCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 29, 2025
Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial.

Juan F Rodríguez-Moreno, Guillermo de Velasco, Carlos Álvarez-Fernández

|Aug 12, 2022
Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients.

Elena Sevillano Fernández, Rodrigo Madurga de Lacalle, Juan Francisco Rodriguez Moreno

|Jan 06, 2022
Behavioural immune landscapes of inflammation.

Georgiana Crainiciuc, Miguel Palomino-Segura, Miguel Molina-Moreno

|Apr 03, 2021
Risk Score for Predicting In-Hospital Mortality in COVID-19 (RIM Score).

Alejandro López-Escobar, Rodrigo Madurga, José María Castellano

|Jan 27, 2021
Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma.

Tomás Duraj, Noemí García-Romero, Josefa Carrión-Navarro

|Jul 08, 2020
Normal tissue content impact on the GBM molecular classification.

Rodrigo Madurga, Noemí García-Romero, Beatriz Jiménez

Pageof 2

Frequent Collaborators

3 joint publications

Noemi García-Romero

2 joint publications

Alfonso M Gañán-Calvo

2 joint publications

Angel Ayuso-Sacido

1 joint publications

José Pérez-Rigueiro